Abstract
Ninety seven new patients with ophthalmic zoster were randomly allocated to three topical treatment groups: acyclovir (ACV) ointment and placebo drops (AP), placebo ointment with steroid drops (PS), and acyclovir ointment with steroid drops (AS). The dosage administered was determined by the score of the ocular inflammation. Follow-up was for at least one year. The results showed that topical ACV alone is insufficient for severe ocular inflammation but is not inclined to lead to recurrences in milder cases. Topical steroid alone is effective but tends to necessitate prolonged treatment. Combined steroid and ACV is questionably better than steroid alone and causes marginally fewer rebound inflammations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bean B., Braun C., Balfour H. H., Jr Acyclovir therapy for acute herpes zoster. Lancet. 1982 Jul 17;2(8290):118–121. doi: 10.1016/s0140-6736(82)91090-x. [DOI] [PubMed] [Google Scholar]
- Cobo L. M., Foulks G. N., Liesegang T., Lass J., Sutphin J. E., Wilhelmus K., Jones D. B., Chapman S., Segreti A. C., King D. H. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986 Jun;93(6):763–770. doi: 10.1016/s0161-6420(86)33678-9. [DOI] [PubMed] [Google Scholar]
- Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsh R. J., Cooper M. Acyclovir and steroids in herpes zoster keratouveitis. Br J Ophthalmol. 1984 Dec;68(12):904–905. doi: 10.1136/bjo.68.12.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsh R. J. Current management of ophthalmic herpes zoster. Trans Ophthalmol Soc U K. 1976 Jul;96(2):334–337. [PubMed] [Google Scholar]
- McGill J., Chapman C. A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis. Br J Ophthalmol. 1983 Nov;67(11):746–750. doi: 10.1136/bjo.67.11.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGill J. Topical acyclovir in herpes zoster ocular involvement. Br J Ophthalmol. 1981 Aug;65(8):542–545. doi: 10.1136/bjo.65.8.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKendrick M. W., McGill J. I., Bell A. M., Hickmott E., Burke C. Oral acyclovir for herpes zoster. Lancet. 1984 Oct 20;2(8408):925–925. doi: 10.1016/s0140-6736(84)90678-0. [DOI] [PubMed] [Google Scholar]
- McKendrick M. W., McGill J. I., Wood M. J. Lack of effect of acyclovir on postherpetic neuralgia. BMJ. 1989 Feb 18;298(6671):431–431. doi: 10.1136/bmj.298.6671.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patterson A., Jones B. R. The management of ocular herpes. Trans Ophthalmol Soc U K. 1967;87:59–84. [PubMed] [Google Scholar]
- Peterslund N. A., Seyer-Hansen K., Ipsen J., Esmann V., Schonheyder H., Juhl H. Acyclovir in herpes zoster. Lancet. 1981 Oct 17;2(8251):827–830. doi: 10.1016/s0140-6736(81)91102-8. [DOI] [PubMed] [Google Scholar]
- Piebenga L. W., Laibson P. R. Dendritic lesions in herpes zoster ophthalmicus. Arch Ophthalmol. 1973 Oct;90(4):268–270. doi: 10.1001/archopht.1973.01000050270002. [DOI] [PubMed] [Google Scholar]
- Poirier R. H., Kingham J. D., de Miranda P., Annel M. Intraocular antiviral penetration. Arch Ophthalmol. 1982 Dec;100(12):1964–1967. doi: 10.1001/archopht.1982.01030040944016. [DOI] [PubMed] [Google Scholar]